Filing Details

Accession Number:
0001127602-17-010543
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-07 15:33:13
Reporting Period:
2017-03-06
Filing Date:
2017-03-07
Accepted Time:
2017-03-07 15:33:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1472091 Edge Therapeutics Inc. EDGE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1276550 J James Loughlin 300 Connell Drive, Suite 4000
Berkeley Heights NJ 07922
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-06 3,000 $9.24 6,000 No 4 P Indirect Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Family Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 19,625 Direct
Footnotes
  1. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.